Concepedia

Almas Siddiqui

AS

Statistics

Publications

11

Citations

872

H-Index

11

Active since

2003

Affiliations

Buck Institute for Research on Aging(Current)

Jamia Hamdard

Hamdard University

Ionis Pharmaceuticals (United States)

Almas Siddiqui is an author at Buck Institute for Research on Aging specializing in neuroscience, life sciences, and neurodegeneration.

Publications per year

2003–2017

11

Publications

11

Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: Implications for Parkinson’s disease

Almas Siddiqui, Shankar J. Chinta, Jyothi K. Mallajosyula et al. · Free Radical Biology and Medicine · 2012 · 181 citations · Full text

, , +14

Dose‐dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences

Khan Shoeb Zafar, Almas Siddiqui, Iqbal Sayeed et al. · Journal of Neurochemistry · 2003 · 156 citations

, , +17

Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington's disease

Almas Siddiqui, Sulay Rivera-Sánchez, María del R. Castro et al. · Free Radical Biology and Medicine · 2012 · 148 citations · Full text

, , +14

Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin

Almas Siddiqui, Dipa Bhaumik, Shankar J. Chinta et al. · Journal of Neuroscience · 2015 · 127 citations · Full text

, , +17

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease

Edilio Borroni, Bernd Bohrmann, Fiona Grueninger et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 84 citations · Full text

, , +17

1–5 of 11